Delivery Order SPE2DB22D9239-SPE2DB23FDJ49

Award Date 5/11/23
Potential Completion Date 6/2/23
Potential Value $188K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML syringes with a potential value of $20,050.65. This delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to supply pharmaceuticals and medical products to military treatment facilities worldwide. The contract does not have a set-aside designation, and the delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Eylea 2 mg/0.05 ml vial. The contract has a completion date of October 4, 2022 and a potential value of $135,794.00. This delivery order is part of a larger indefinite delivery contract between DMS Pharmaceutical Group and DLA Troop Support Medical to provide a variety of pharmaceutical and medical supplies to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML SYRINGE 0.05ML. The $128,953.90 contract has a completion date of January 19, 2024. This delivery order is part of a larger indefinite delivery contract with DMS Pharmaceutical Group to supply various pharmaceutical and medical products to military treatment facilities globally. The contract does not have a set-aside...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML VIAL 0.05ML. This delivery order, valued at $5,253.92, has a completion date of February 1, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of pharmaceutical and medical products to support military treatment facilities worldwide through various DLA contracts and indefinite...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML VIAL 0.05ML. This delivery order, valued at $135,794.00, is issued against an existing indefinite-delivery contract held by DMS Pharmaceutical Group to supply pharmaceuticals and medical supplies to military treatment facilities worldwide. The contract does not have a set-aside designation. DMS Pharmaceutical Group is a leading...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product EYLEA 2 MG/0.05 ML VIAL 0.05ML. This delivery order, valued at $134,355.50, was issued against an existing indefinite delivery contract between DMS Pharmaceutical Group and DLA to supply various medical supplies and pharmaceutical products to support military treatment facilities globally. The delivery order has a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $10,507.84, is for the supply of EYLEA (aflibercept) 2 mg/0.05 mL vials. The order is part of a larger single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which has a ceiling value of up to...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide Eylea 2 mg/0.05 ml vial 0.05 ml for a potential value of $32,837.00. The delivery order has a completion date of January 23, 2024. DMS Pharmaceutical Group is an established federal contractor that holds a variety of contracts and indefinite delivery vehicles with DLA Troop Support Medical to supply...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of EYLEA 2 MG/0.05 ML SYRINGE 0.05ML pharmaceutical products. This award, valued at $120,714.60, has a completion date of April 17, 2023. DMS Pharmaceutical Group holds various federal contracts and indefinite delivery vehicles (IDVs) to provide a range of pharmaceutical and medical supplies to support military treatment facilities...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,253.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with a completion date of August 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. valued at up to...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB23FDJ49
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA (aflibercept) 2 mg/0.05 ml vials. The $188,097.70 delivery order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group with DLA Troop Support Medical to supply a wide range of pharmaceutical and medical products to military treatment facilities worldwide. This contract vehicle has a potential value of up to $5 million through December 2025. The delivery order has a completion date of June 2, 2023. The contract was not set aside for any specific business category.

Generated 3/22/24, 5:31 PM